A Closer Look at the RAND Study on MediCann Patients



Today, the Legalization Nation print column reported on a new study, co-authored by the independent think tank RAND Corporation, which analyzed just who is getting medical marijuana recommendations in California. The paper's primary author, Dr. Helen Nunberg of the RAND Corporation, as well as researcher Amanda Reiman, say the data shine a rare light on a severely under-researched (and often maligned) population. Follow the jump to download the study and read it yourself.

Download "An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California" here. Some highlights:

- more than half of the roughly 1,650 California MediCann applicants included in the sample were over 35

- 67.8 percent of them brought medical records to their appointment

- 73 percent had health insurance

- 68.7 percent were employed

- Most of them sought relief from chronic pain, insomnia, and anxiety; 79.5 percent had previously tried prescription medications.

- More than 50 percent of the sample reported they had used or were using marijuana as a substitute for prescription drugs.